BioNexus Gene Lab Corp (BGLC)
Data as of , from SEC Form 4 filings.
See up to 3 months of BGLC. The 7-day demo opens the 1M and 3M ranges and puts BGLC on your watchlist.
Start 7-day demoLatest BGLC insider trades
About BioNexus Gene Lab Corp (BGLC)
BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.
- KUALA LUMPUR
- 1
- 2020
- Nasdaq
https://www.bionexusgenelab.comSEC filings for BGLC on EDGAR
BGLC Form 4 activity by transaction type, last 90 days
No Form 4 activity for BGLC in the last 90 days.
BGLC insider transactions (Form 4)
55 Form 4 filings on record, the earliest from Aug 14, 2026, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Lee Su-Leng Tan - Officer | Grant or award | Common Shares | 338,709 | - footnote F1 | - | |
| ||||||
| Chee Keong Yap - Director | Grant or award | Common Shares | 32,258 | - footnote F1 | - | |
| ||||||
| Abdul Hamid Muhammad Azrul Bin - Director | Grant or award | Common Shares | 32,258 | - footnote F1 | - | |
| ||||||
| Set Fui Chong - Officer | Grant or award | Common Shares | 96,774 | - footnote F1 | - | |
| ||||||
| Jook Yuen Low - Director | Grant or award | Common Stock | 16,129 | - footnote F1 | - | |
| ||||||
BGLC insider trading FAQ
What is the latest insider trade for BGLC?
BioNexus Gene Lab Corp (BGLC) has filed no insider reports in the last 90 days. The most recent on record is dated 14 August 2026. The full record for BGLC runs to 5 Form 4 filings, the earliest from 14 August 2026. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying BGLC stock?
No insider purchases of BGLC were filed in the last 90 days.
How many insiders are selling BGLC stock?
No insider sales of BGLC were filed in the last 90 days.
Where can I see BGLC SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects BGLC Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
5The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Lee Su-Leng Tan view on EDGAR
- - Chee Keong Yap view on EDGAR
- - Abdul Hamid Muhammad Azrul Bin view on EDGAR
- - Set Fui Chong view on EDGAR
- - Jook Yuen Low view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where BGLC's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow BGLC with a 7-day demo
- BGLC on your watchlist
- Every BGLC Form 4 filing on record
- Up to 3 months of BGLC price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive